MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)

    C.E. Clarke, S. Patel, N. Ives, C. Rick, A. Gray, C. Jenkinson, E. McIntosh, K. Wheatley, A. Williams, R. Gray (Birmingham, United Kingdom)

  • Randomized controlled trial protocol: Balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

    T.T.C. Capato, J. Tornai, V.F. Gianguiagi, R.R. Firmino, E.R. Barbosa, M.E. Piemonte (São Paulo, Brazil)

  • Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

    J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

  • Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial

    W. Schrempf, M. Fauser, K. Otto, M. Wienecke, C. Ossig, S. Brown, A. Maass, M.D. Brandt, U. Schwanebeck, X. Graehlert, H. Reichmann, A. Storch (Dresden, Germany)

  • RBD increase non-motor symptom in Parkinson’s disease

    Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)

  • RE-024: A potential phosphopantothenate replacement therapy in 2 patients with pantothenate kinase-associated neurodegeneration (PKAN)

    P. Roa, P. Stoeter, E. Perez, M. Santana (Santo Domingo, Dominican Republic)

  • RE-024: Mechanism of action and efficacy in non-clinical models

    M. Beconi, E. Monteagudo, A. Di Marco, S. Malancona, D. Elbaum, S. Harper (San Diego, CA, USA)

  • Re-emergent tremor in Parkinson’s disease: Epidemiological and clinical features

    D. Belvisi, A. Conte, M. Bologna, A. Suppa, M. Costanzo, M.C. Bloise, A. Formica, P. Stirpe, G. Fabbrini, A. Berardeli (Pozzilli, Italy)

  • Reach-to-grasp impairments of both hands in individuals with Parkinson’s disease

    S. Khacharoen, J. Tretriluxana, A. Pisarnpong, P. Chaiyawat (Nakhon Pathom, Thailand)

  • Real world conversion of levodopa to a novel extended release levodopa preparation: Determining predictors and dose ratios

    W. Ondo, P. Coss, M. Christie (Houston, TX, USA)

  • Real-life data on the use of levodopa carbidopa intestinal gel in Parkinson’s disease

    J.T. Butler, D. Isaacs, C. Tolleson, R. Pierce, T. Davis (Nashville, TN, USA)

  • Real-time ultrasound for automated analysis and visualization of neck muscles in cervical dystonia

    C. Kobylecki, M.A. Silverdale, R. Cunningham, P. Harding, I.D. Loram (Salford, United Kingdom)

  • Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant

    M.C. Schiess, L. Tonder, M. Wells, T. Weaver, V. Stoker (Houston, TX, USA)

  • Recent result of indicative evaluation for deep brain stimulation of Parkinson’s disease patients

    H. Saiki, S. Matsumoto (Osaka, Japan)

  • Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems

    T. Weaver, P. Konrad, L. Timmerman, G. Molnar, K. Stromberg (Minneapolis, MN, USA)

  • Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone

    J. Runge, A. Wloch, M. Abdallad, M. Manu, J.K. Krauss (Hannover, Germany)

  • Recognition of parkinsonism in African Americans in a community-based sample

    D.A. Hall, B. Ouyang, J.M. Shulman, L.M. Shulman, D.A. Bennett, L.L. Barnes (Chicago, IL, USA)

  • Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies

    A. Tankus, A. Mirelman, N. Giladi, I. Fried, J.M. Hausdorff (Tel-Aviv, Israel)

  • Reduced lifespan and climbing ability observed in the overexpressing human α-synuclein without heat shock protein CNB115 in Parkinson’s disease drosophila line

    M.S. Islam, H.J. Kim, S.S. Hong (Jeonju, Korea)

  • Reduced thalamo-cortical functional connectivity in asymptomatic LRRK2 mutation carriers

    D. Vilas, B. Segura, C. Pont-Sunyer, M.J. Martí, Y. Compta, F. Valldeoriola, H. Baggio, M. Quintana, A. Bayés, J. Hernández-Vara, M. Calopa, M. Aguilar, C. Junqué, E. Tolosa (Barcelona, Spain)

  • Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy

    F. Bassil, P.O. Fernagut, E. Bezard, Q. Hoang, D. Ringe, G.A. Petsko, W.G. Meissner (Bordeaux, France)

  • Reduction in battery longevity for each subsequent implantable pulse generator (IPG) in patients with Parkinson’s disease (PD) treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS) may be due to both programming changes and IPG model – a case series

    S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin, S. Hassin (Ramat Gan, Israel)

  • Refined basal ganglia model accounting for GPi modulation of thalamic tonic and burst modes

    M.S. Baron, D. Kumbhare (Richmond, VA, USA)

  • Reflex saccades changes can estimate long-term symptom progression in DBS STN and MED Parkinson’s disease patients (PD)

    S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

  • Regional differences in the results of a phase 2b study of tozadenant in Parkinson’s disease patients with motor fluctuations

    C. Kenney, K. Kieburtz, W. Olanow, S. Bandak (San Francisco, CA, USA)

  • Regular exercise is associated with better two-year outcomes in Parkinson’s disease: National Parkinson foundation quality improvement initiative (NPF-QII) data

    M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)

  • Regulation in speech motor control in ET patients treated with DBS: Kinematics of the lingual and the labial systems

    D. Muecke, A. Hermes, M.T. Barbe, T.B. Roettger, N. Henrik, J. Becker, M. Hartinger, I. Meister, V. Visser-Vandewalle, L. Timmermann, M. Grice (Cologne, Germany)

  • Rehabilitation of dysphagia in Parkinson’s disease: Effect of chin-down postural maneuver

    A. Ayres, G.P. Jotz, C.R.M. Rieder, M.R. Olchik (Porto Alegre, Brazil)

  • Relation between personality trait and depression in Parkinson’s disease

    A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

  • Relation between the clinical features and the standardized heart to mediastinum ratio in cardiac metaiodobenzylguanidine imaging in patients with Parkinson’s disease: A multicenter cross-sectional study

    T. Osada, Y. Morita, K. Ohta, S. Nogawa, K. Takahashi, K. Yamaguchi, D. Yasutomi, M. Seki, Y. Nihei, S. Iwasawa, N. Suzuki (Tokyo, Japan)

  • Relationship between Alzheimer’s disease GWAS-linked top hits and risk of Parkinson’s disease with or without cognitive decline: A Chinese population-based study

    J.F. Guo, Y.Q. Wang, X.X. Yan, B.S. Tang (Changsha, People's Republic of China)

  • Relationship between balance, trunk impairment and hand function in Parkinson’s disease

    B. Donmez Colakoglu, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)

  • Relationship between cognitive functions and striatal 123I-FP-CIT uptake in Parkinson’s disease

    H. Sawada, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)

  • Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2

    K. Suzuki, A. Numao, T. Kadowaki, S. Suzuki, Y. Watanabe, M. Miyamoto, T. Miyamoto, T. Uchiyama, K. Hashimoto, H. Fujita, Y. Watanabe, T. Matsubara, K. Hirata (Mibu, Japan)

  • Relationship between freezing and pedunculopontine nucleus’ size in Parkinson’s disease: Semi quantitative analysis based on MRI with modified FGATIR sequence

    S. Chen, M. Tir, P. Monet, J.M. Constans, O. Godefroy, M. Lefranc, P. Krystkowiak (Amiens, France)

  • Relationship between sensory augmentation and exercise routine in the improvement in balance and gait in a patient with lithium-induced ataxia

    M.D. Maldonado (Santiago, Chile)

  • Relationship between the MDS-UPDRS and quality of life in Parkinson’s disease: A large international multicenter study of 3206 patients (the QUALPD study)

    M. Škorvánek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A.E. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gerschanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

  • Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease

    B.A. Bernard, D. Carns, G.T. Stebbins, J.G. Goldman, C.G. Goetz (Chicago, IL, USA)

  • Relationship of muscular strength with cardiovascular function in Parkinson’s disease

    M.A. Alomari, H. Khalil, O.F. Khabour, E. Dersieh, J.A. Bajwa (Irbid, Jordan)

  • Relationship of serum ferritin level and tic severity in children with Tourette syndrome

    D. Ghosh, E.L. Burkman (Columbus, OH, USA)

  • Relationships of cognitive functions and psychiatric symptoms with motor phenotypes in patients with untreated early-stage Parkinson’s disease

    H. Terashi, Y. Ishimura, T. Taguchi, H. Mitoma, H. Aizawa (Tokyo, Japan)

  • Relative hypoglycemia induces acute chorea followed by chronic parkinsonism in a diabetic patient on hemodialysis: A case with sequential clinico-radiological correlate

    K.J. Lizarraga, D. Adams, L.C. Alexandre, C. Singer (Miami, FL, USA)

  • Reliability and responsiveness of in-clinic and at-home app-based bradykinesia assessment

    D.A. Heldman, E. Urrea Mendoza, L.C. Lovera, D.A. Schmerler, J.P. Giuffrida, A.J. Espay, J.X.O. Garcia, M.E. Mohammad, M.C.U. McFarlane, H.H. Fernandez (Cleveland, OH, USA)

  • Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)

    J.A. Simons, S. von Clarmann, T. Warnecke (Lübeck, Germany)

  • Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease

    T.E. Apoznanski, S. Yao, M.K. Jung, J. DiFrancisco-Donoghue (Old Westbury, NY, USA)

  • Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?

    M.R. Olchik, M. Ghisi, A. Freiry, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

  • Repeat size and X-inactivation in the clinical phenotype of fragile X premutation carrier sisters: A familial case series

    D.A. Hall, E. Robertson, J.A. O'Keefe, A.G. Hadd, L. Zhou, E. Berry-Kravis (Chicago, IL, USA)

  • Research of vestibular evoked myogenic potentials (VEMP) in the diagnosis of postural instability in Parkinson’s disease

    O.A. Alenicova, S.A. Likhachev (Minsk, Belarus)

  • Resetting tremor by single pulse transcranial magnetic stimulation at the motor cortex and the cerebellum in essential tremor and dystonic tremor

    P. Panyakaew, H.J. Cho, P. Srivanitchapoom, M. Hallett (Bethesda, MD, USA)

  • Response inhibition in Parkinson’s disease

    J. Kim, K. Zhang, M.A.I.U.A. Cruadhlaoich, S. YorkWilliams, V. Menon, K.L. Poston (Stanford, CA, USA)

  • Response to thermal and pain stimulation and genetic variance for pain in patients with Parkinson’s disease – Are they all related?

    A. Khlebtovsky, R. Dabby, Y. Rodity, I. Steiner, R. Djaldetti (Petach Tikva, Israel)

  • Resting state functional connectivity in olfactory network in de novo Parkinson’s disease

    S. Marino, L. Bonanno, F. Caminiti, F. Corallo, V. Lo Buono, S. De Salvo, G. Di Lorenzo, P. Bramanti (Messina, Italy)

  • Resting-state functional connectivity of subthalamic nucleus in different phenotypes of Parkinson’s disease

    Z. Wang, H. Chen, H. Ma, L. Ma, T. Wu, T. Feng (Beijing, People's Republic of China)

  • Results from a double-blind trial of pallidal DBS for Tourette’s syndrome: Are there any predictors of surgery outcome?

    Z. Kefalopoulou, L. Zrinzo, M. Jahanshahi, J. Candelario, C. Milabo, M. Beigi, H. Akram, J. Hyam, J. Clayton, L. Kass-Iliyya, M. Silverdale, J. Evans, P. Limousin, M. Hariz, E. Joyce, T. Foltynie (London, United Kingdom)

  • Results of the German registry of pediatric deep brain stimulation in patients with childhood-onset dyskinetic movement disorders (GEPESTIM)

    A. Koy, W. Milena, K.A.M. Pauls, A.A. Kühn, P. Krause, J. Hübl, G.H. Schneider, G. Deuschl, R. Erasmi, D. Falk, J.K. Krauss, G. Lütjens, A. Schnitzler, L. Wojtecki, J. Vesper, R. Korinthenberg, V.A. Coenen, V. Visser-Vandewalle, M. Hellmich, L. Timmermann (Cologne, Germany)

  • Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease

    C.J. Mao, Z.J. Yang, J. Wei, J.R. Zhang, Y.P. Yang, C.F. Liu (Suzhou, People's Republic of China)

  • Retrieval action verbs is impaired in Parkinson´s disease patients using a sentence completion task

    E. Herrera, R. Pérez, M. González-Nosti (Gijón, Spain)

  • Reward insensitivity differentiates apathy from depression in Parkinson’s disease

    K. Muhammed, M. Ben Yehuda, D. Drew, S. Manohar, T. Chong, G. Tofaris, M. Bogdanovic, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)

  • Risk factors associated with postural changes in Parkinson’s disease

    A. Khlebtovsky, O. Keret, Y. Rodity, G. Tsvetov, I. Slutzcki-Shraga, F. Benninger, R. Djaldetti (Petach Tikva, Israel)

  • Risk factors for premature withdraw from the LS-1 PD study

    J.Y. Fang, S. Luo, M. Huang, R.B. Dewey, R. Hauser, G. Chen (Nashville, TN, USA)

  • Risk factors of wearing-off phenomenon in Parkinson’s disease in Japan

    J. Fukae, S. Ouma, K.I. Kashihara, N. Hattori, Y. Tsuboi (Fukuoka, Japan)

  • Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders

    M.V. Rey, L. Molina, B. Recinos, B. Paz, M. Rovelo, F.E. Rodriguez Elias, J. Calderon, A. Arellano, S. Pomata, S. Perez-Lloret, CA-APD Study Team (Buenos Aires, Argentina)

  • Risk prediction modeling in Parkinson’s disease using genetic and environmental/lifestyle factors

    C.M. Lill, Y.H. Chuang, J. Hansen, P.C. Lee, N. Greene, C. Klein, H. Binder, B. Ritz, L. Bertram (Lübeck, Germany)

  • Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia

    K.H. Goh, H.L. Ng, K.Y. Tay, S. Acharyya, S.Y.E. Ng, J.P.L. Boo, A.H.J. Kooi, W. Li, W.L. Au, L.C.S. Tan (Singapore, Singapore)

  • Robust sensorimotor deficits in a knock-in mouse model of primary torsion dystonia

    F. Richter, J. Gerstenberger, A. Bauer, C. Helmschrodt, A. Richter (Leipzig, Germany)

  • Role of contact polarity on therapeutic impedances at two deep brain stimulation (DBS) targets

    N. Bukhari, B.H. Kopell, R.A. Ramdhani (New York, NY, USA)

  • Role of dopamine and GABA during subthalamic and pallidal deep brain stimulation: Evidence of dopamine release during subthalamic Deep Brain Stimulation

    A. Nakajima, Y. Shimo, T. Uka, N. Hattori (Tokyo, Japan)

  • Role of macroautophagy in regulating microglia-mediated neuroinflammation and dopaminergic neuron injury

    M. Jin, L. Hu, C. Liu (Suzhou, People's Republic of China)

  • Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia

    G. Gangarossa, M. Guzman, V. Prado, M. Prado, S. Daumas, S. El Mestikawy, E. Valjent (Paris, France)

  • Role of the nurse coordinator within a unit for treatment of neuro-surgical behaviours and abnormal movements

    E. Borgeais, C. Fournera, I. Creff, P. Coubes (Montpellier, France)

  • Roles of combined functional catechol-o-methyltransferase genotypes in Chinese Parkinson’s disease: A cross-sectional survey

    Y. Qian, X. Yang, S. Xu, J. Liu, Q. Xiao (Shanghai, People's Republic of China)

  • Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants

    S.M. Goldman, F. Kamel, C. Meng, M. Korell, D.M. Umbach, J. Hoppin, G.W. Ross, C. Marras, M. Kasten, A. Chade, K. Comyns, D. Sandler, A. Blair, C.M. Tanner (San Francisco, CA, USA)

  • Rotigotine transdermal patch in Chinese patients with advanced Parkinson’s disease: A randomized, double-blind study

    Z. Zhang, M. Asgharnejad, H. Xue, E. Surmann, L. Bauer (Beijing, People's Republic of China)

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley